Jesse Shefferman - Jan 10, 2023 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Mary Grendell, Attorney-In-Fact
Stock symbol
TARA
Transactions as of
Jan 10, 2023
Transactions value $
-$17,565
Form type
4
Date filed
1/11/2023, 03:03 PM
Previous filing
Jan 4, 2023
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability -$17.6K -5.86K -0.67% $3.00 867K Jan 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020.